Related Experiment Video
Updated: Jul 17, 2025
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
Published on: December 15, 2023
Budd-Chiari Syndrome following COVID-19 infection: a case report
Seri S Sawaqed1, Heba M Urabi2, Mohammad H Al-Thnaibat1
1Faculty of Medicine, Hashemite University, Zarqa.
Insights
Coronavirus disease 2019 (COVID-19) can increase Budd-Chiari Syndrome (BCS) risk due to inflammation and clotting. Early detection of hepatosplenomegaly and abdominal distention post-COVID-19 is crucial for prompt BCS management.
Area of Science:
- Hepatology
- Vascular Medicine
- Infectious Diseases
Background:
- Budd-Chiari Syndrome (BCS) is a rare hepatic vein obstruction.
- Coronavirus disease 2019 (COVID-19) is associated with hypercoagulability and inflammation.
- COVID-19 may precipitate BCS development in susceptible individuals.
Introduction And Importance:
Budd-Chiari Syndrome (BCS) is a rare disorder that affects the liver and is caused by blockage of the hepatic veins. Coronavirus disease 2019 (COVID-19) has been linked to an increased risk of developing BCS due to its ability to cause inflammation in the body, which can lead to clotting disorders.
Case Presentation:
A 43-year-old female presented to the emergency department complaining of severe epigastric and right upper quadrant pain and progressive abdominal distention. Upon examination, investigation, and triphasic liver computed tomography with contrast, the patient was diagnosed with BCS.
Clinical Discussion:
The patient was started on anticoagulant therapy with low-molecular-weight heparin and supportive treatment. She was hospitalized for 3 weeks and discharged on oral warfarin 5 mg/day after showing clinical improvement.
Conclusion:
Hepatosplenomegaly and abdominal distention after COVID-19 infection raise suspicion for BCS. Therefore, early detection of these signs is essential for immediate management.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:30Acute Pancreatitis II: Clinical Manifestations and Management